Indefinite Delivery Contract SPE2DU25D1211

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a 30-month base period and three 30-month option periods, running through December 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999 contract, with an ultimate completion date of December 31, 2036, is an unrestricted, fully competitive acquisition to establish Pharmaceutical Prime Vendor Global Program Generation V contracts. The purpose is to provide worldwide pharmaceutical support,...
The Indefinite Delivery Contract (IDC) SPE2DR25D6035 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is a single-award IDC with a period of performance through December 31, 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 IDC, with a period of performance through December 2036, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract aims to...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999 single-award IDC, valid through December 31, 2036, is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement, which aims to establish multiple prime vendor contracts to provide worldwide pharmaceutical support to...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies supporting military healthcare programs globally. The $4,999,999 contract has a period of performance through December 31, 2036 and is designated as a single award with no set-asides used. The IDC is part of the DLA's...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, valued at $999,999,999, runs through December 2036 and covers critical medical commodities including specialty medications,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a base period of 30 months and three 30-month option periods, running through December 2036. The purpose of this IDC is to establish Pharmaceutical Prime Vendor contracts to provide worldwide pharmaceutical support to various...
The Indefinite Delivery Contract (IDC) SPE2DR25D2206 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract, running through December 2036, is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a period of performance through December 2036 and aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense...

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999,999 single-award contract, which runs through December 2036, is part of DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) acquisition.

The purpose of this IDC is to establish a contract vehicle for Amerisourcebergen to provide worldwide pharmaceutical support, including brand-name, generic, and specialty drugs, as well as related medical supplies, to the Department of Defense, United States Coast Guard, and other government agencies. The contract encompasses a broad range of medical commodities across multiple therapeutic areas to support normal day-to-day operations, planned and unplanned contingencies, and readiness requirements at both CONUS and OCONUS locations. This fully competitive, Lowest Price Technically Acceptable acquisition will result in multiple regional primary supplier awards and a separate backup supplier award, ensuring resiliency in the pharmaceutical supply chain.

Generated 6/6/25, 10:08 AM